Login / Signup

Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging.

Norihiro KobayashiKeisuke HiranoMasahiro YamawakiMotoharu ArakiTsuyoshi SakaiYasunari SakamotoShinsuke MoriMasakazu TsutsumiMasahiro NauchiNaohiko SaharaYohsuke HondaKenji MakinoShigemitsu ShiraiMasafumi MizusawaYuta SugizakiTakahide NakanoTomoya FukagawaToshihiko KishidaYuki KozaiYusuke SetonagaShutaro GodaYoshiaki Ito
Published in: SAGE open medical case reports (2020)
A 63 year-old woman with claudication underwent endovascular therapy for diffuse stenosis of the right superficial femoral artery in our hospital. We performed paclitaxel-coated balloon angioplasty using the IN.PACT™ Admiral™ and achieved acceptable results. After 42 days, we performed follow-up optical frequency domain imaging for the right superficial femoral artery lesion treated with paclitaxel-coated balloon and observed several high-intensity regions with attenuation on the lumen surface. Sustained drug availability is a notable characteristic of paclitaxel-coated balloon. To the best of our knowledge, this is the first report on the visualization of sustained drug retention on the lumen surface using follow-up optical frequency domain imaging after paclitaxel-coated balloon angioplasty in a human patient with superficial femoral artery disease.
Keyphrases
  • high resolution
  • high intensity
  • healthcare
  • adverse drug
  • high speed
  • resistance training
  • case report
  • fluorescence imaging
  • induced pluripotent stem cells
  • aortic dissection
  • acute care